Amgen Inc (AMGN)

[garywoodruff]

This is why you buy Nviv read and learn ,This is a post from a doctor, buy and hold for your kids or grandkids don,t worry this poster says it all here it is:I recently found this forum and wanted to share my opinion on where things stand today. I've held NVIV for the past 2 months pre-split. I happen to be a physician who sees patients with various types of nerve injury. I don't have any inside knowledge or contacts and everything I express here is my opinion based on what is public. I also write with the intent to respect the persons who have enrolled in the study.

NVIV offers the best hope for SCI patients today. Treatment has consisted of 1) Decompression 2) Steroids 3) Rehab 4) Prayers. The neuroscaffold (NS) has excellent basic science evidence and a good rational for why it works. At 90 days, patient #1 progressed from AIS-A to AIS-C. Less certain is Patient #2's status.

Patient #2 apparently had injury at the T5 level. Since then, she has shown ~2/5 hip flexion (L1-L2) and ~2/5 knee extension (L3). Note that her knee extension is likely improved compared to what is documented in Jordan's 90 day exam. Most spine patients do not improve more than 2-3 spine segments below the level of injury. She has thus far shown a 10 level improvement.

Now, there have been many questions about B&B, sometimes to the extent of disrespecting the privacy of the patients. Return of B&B is VERY important for the patients, but not as important to investors. Here's why:

Pathophysiology of spinal cord injury. Recovery after immediate and delayed decompression.
(JBJS Scientific Journal)

Patient #2 had a 2 day delay in decompression. We know from animal studies that 24H delay reduces B&B return by 70%. In clinical practice, our target is MRI in 1-2 hours and decompression within 6 hours. Hence, it is rather remarkable that she has had a 10 level improvement after such delay. Return of B&B would be ~16 levels from T5 (maybe less due to autonomic innervation).

Why I invest in NVIV: I see SCI patients regularly and I would love to see this technology benefit my patients .
sy2246 Less